Funds and ETFs Lifecore Biomedical, Inc.

Equities

LFCR

US5147661046

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
6.595 USD -0.68% Intraday chart for Lifecore Biomedical, Inc. -1.42% +6.54%

ETFs positioned on Lifecore Biomedical, Inc.

Name Weight AuM 1st Jan change Investor Rating
0.00% 9 M€ +6.26% -
0.00% 147 M€ +4.88% -
0.00% 18 M€ +3.86% -
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.595 USD
Average target price
6 USD
Spread / Average Target
-9.02%
Consensus
  1. Stock Market
  2. Equities
  3. LFCR Stock
  4. Funds and ETFs Lifecore Biomedical, Inc.